🇺🇸 FDA
Company

ACTUATE

ACTUATE THERAPEUTICS, INC.

ACTU pharma USA

Quick answer

ACTUATE is a pharma company (ACTU) headquartered in FORT WORTH, TX, USA with 11 tracked pipeline programs.

Pipeline (11)

project

9-ING-41

Salivary Gland Carcinoma

Phase 2 · small_molecule · terminated

1 trials project

9-ING-41

Pancreatic Adenocarcinoma

Phase 2 · small_molecule · terminated

1 trials project

9-ING-41

Cancer

Phase 2 · small_molecule · active

1 trials project

9-ING-41

Salivary Gland Cancer

Phase 2 · small_molecule · active

1 trials project

FOLFIRNINOX

Pancreatic Adenocarcinoma

Phase 2 · small_molecule · active

1 trials project

Gemcitabine

Sarcoma

Phase 2 · small_molecule · terminated

1 trials project

Gemcitabine

Soft Tissue Sarcoma

Phase 2 · small_molecule · terminated

1 trials project

Ruxolitinib

Myelofibrosis

Phase 2 · small_molecule · completed

1 trials project

9-ING-41

Refractory Cancer

Phase 1 · small_molecule · terminated

1 trials project

Retifanlimab

Pancreatic Adenocarcinoma

Phase 1 · small_molecule · active

1 trials project

Megestrol acetate

HIV Infections

Unknown · small_molecule · completed

1 trials

Patents (7)

patent

US 12145943

Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]ind

Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12116374

Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]ind

Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12083098

Treatment of idiopathic pulmonary fibrosis with glycogen synthase kinase 3 form

Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11980607

Methods of treating malignant lymphoproliferative disorders

Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11510904

Methods of treating malignant lymphoproliferative disorders

Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11407759

Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]ind

Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11136334

Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]ind

Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)